Modified GAP index for prediction of acute exacerbation of idiopathic pulmonary fibrosis in non-small cell lung cancer-Reference-Cited by-同舟云学术

Modified GAP index for prediction of acute exacerbation of idiopathic pulmonary fibrosis in non-small cell lung cancer

Published:2017-05-23 Issue:7 Volume:22 Page:1379-1385
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

Kobayashi Haruki¹^ORCID,Omori Shota¹,Nakashima Kazuhisa¹,Wakuda Kazushige¹,Ono Akira¹,Kenmotsu Hirotsugu¹,Naito Tateaki¹,Murakami Haruyasu¹,Endo Masahiro²,Takahashi Toshiaki¹

Affiliation:

1. Division of Thoracic Oncology; Shizuoka Cancer Center; Shizuoka Japan

2. Division of Diagnostic Radiology; Shizuoka Cancer Center; Shizuoka Japan

Funder

AstraZeneca

Boehringer Ingelheim

Ono Pharmaceutical

Eli Lilly

Chugai Pharmaceutical

Pfizer

Takeda Pharmaceutical

Taiho Pharmaceutical

MSD

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.13075/fullpdf

Reference20 articles.

1. Exacerbation of idiopathic interstitial pneumonias associated with lung cancer therapy;Minegishi;Intern. Med.,2009

2. Clinical characteristics of acute respiratory deterioration in pulmonary fibrosis associated with lung cancer following anti-cancer therapy;Isobe;Respirology,2010

3. Chemotherapy for non-small cell lung cancer complicated by idiopathic interstitial pneumonia;Kinoshita;Oncol. Lett.,2012

4. The efficacy and safety of chemotherapy in patients with nonsmall cell lung cancer and interstitial lung disease: a PRISMA-compliant Bayesian meta-analysis and systematic review;Chen;Medicine (Baltimore),2015

5. Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease;Kenmotsu;Cancer Chemother. Pharmacol.,2015

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute exacerbation predicting poor outcomes in idiopathic interstitial pneumonia and advanced lung cancer patients undergoing cytotoxic chemotherapy;Scientific Reports;2024-05-03

2. Treatment Strategies for Non-Small-Cell Lung Cancer with Comorbid Respiratory Disease; Interstitial Pneumonia, Chronic Obstructive Pulmonary Disease, and Tuberculosis;Cancers;2024-04-29

3. Modified blood cell GAP model as a prognostic biomarker in idiopathic pulmonary fibrosis;ERJ Open Research;2024-03-28

4. Current pharmacotherapies for advanced lung cancer with pre-existing interstitial lung disease : A literature review and future perspectives;The Journal of Medical Investigation;2024

5. Chemotherapy versus best supportive care in advanced lung cancer and idiopathic interstitial pneumonias: A retrospective multi-centre cohort study;Respiratory Investigation;2023-03